Tag Archives: from

Viewpoints: The FDA Isn’t Up To The Task Of Reining In The Opioid Epidemic; The Downside Of Taking Children From Parents In Drug Treatment

Editorial writers weigh in on these and other health care topics. The Washington Post: This Is Why The Federal Government Has A Hard Time Regulating Prescription Opioids This past week, President Trump argued on national television that to end the opioid epidemic, Congress needed to fund the building of a wall at the United States’… Read More »

Supreme Court rebuffs appeals from Merck, Gilead in 2 high-profile drug battles

Monday was a good-news-bad-news day for Gilead Sciences at the U.S. Supreme Court, with the justices handing down multiple decisions about which appeals they would take up as they headed back to work after the holiday break. SCOTUS refused to hear Gilead’s appeal in a whistleblower case alleging it lied to the FDA about unapproved… Read More »